Compare BSX & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | MDT |
|---|---|---|
| Founded | 1979 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.7B | 114.9B |
| IPO Year | 1992 | N/A |
| Metric | BSX | MDT |
|---|---|---|
| Price | $92.54 | $99.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 18 |
| Target Price | ★ $125.33 | $108.63 |
| AVG Volume (30 Days) | ★ 9.8M | 7.7M |
| Earning Date | 10-22-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 2.84% |
| EPS Growth | ★ 54.68 | 12.98 |
| EPS | 1.87 | ★ 3.69 |
| Revenue | $19,349,000,000.00 | ★ $34,758,000,000.00 |
| Revenue This Year | $21.05 | $8.60 |
| Revenue Next Year | $11.43 | $5.83 |
| P/E Ratio | $49.51 | ★ $27.06 |
| Revenue Growth | ★ 21.61 | 5.34 |
| 52 Week Low | $85.98 | $79.29 |
| 52 Week High | $109.50 | $106.33 |
| Indicator | BSX | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 33.35 | 51.68 |
| Support Level | $91.45 | $99.49 |
| Resistance Level | $93.89 | $101.39 |
| Average True Range (ATR) | 2.10 | 1.63 |
| MACD | -0.83 | -0.56 |
| Stochastic Oscillator | 10.42 | 11.81 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.